New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Treating newly-diagnosed Crohn's patients with advanced therapy leads to dramatic improvements in outcomes

Treating newly-diagnosed Crohn's patients with advanced therapy leads to dramatic improvements in outcomes

FEBRUARY 22, 2024 Editors' notesbyUniversity of CambridgeHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaA large-scale clin
Gastroenterology March 14,2024
Treating newly-diagnosed Crohn's patients with advanced therapy leads to dramatic improvements in outcomes

Treating newly-diagnosed Crohn's patients with advanced therapy leads to dramatic improvements in outcomes

FEBRUARY 22, 2024 Editors' notesbyUniversity of CambridgeHigh magnification micrograph of Crohn's disease. Biopsy of esophagus. H&E stain. Credit: Nephron/WikipediaA large-scale clin
Gastroenterology March 14,2024
High efficacy and good safety profile for the R21/Matrix-M malaria vaccine in African children

High efficacy and good safety profile for the R21/Matrix-M malaria vaccine in African children

FEBRUARY 2, 2024 Editors' notesbyUniversity of OxfordKaplan-Meier estimates of the time to first episode of clinical malaria in the modified per-protocol population at seasonal sites (A), st
Public Health & Prevention March 14,2024
High efficacy and good safety profile for the R21/Matrix-M malaria vaccine in African children

High efficacy and good safety profile for the R21/Matrix-M malaria vaccine in African children

FEBRUARY 2, 2024 Editors' notesbyUniversity of OxfordKaplan-Meier estimates of the time to first episode of clinical malaria in the modified per-protocol population at seasonal sites (A), st
Public Health & Prevention March 14,2024
Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA
Oncology March 14,2024
Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

Protein identified as a potential biomarker and therapeutic target for aggressive neuroendocrine carcinomas

JANUARY 29, 2024 Editors' notesby Denise Heady,University of California, Los AngelesCredit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2023.101381Investigators from the UCLA
Oncology March 14,2024
Case study: Drug-resistant bacteria responds to phage-antibiotic combo therapy

Case study: Drug-resistant bacteria responds to phage-antibiotic combo therapy

FEBRUARY 14, 2024 Editors' notesbyUniversity of PittsburghCredit: CC0 Public DomainIt was a last-ditch effort. For years doctors had tried to keep a patient's recurrent drug-resistant ba
Breakthroughs March 14,2024
Case study: Drug-resistant bacteria responds to phage-antibiotic combo therapy

Case study: Drug-resistant bacteria responds to phage-antibiotic combo therapy

FEBRUARY 14, 2024 Editors' notesbyUniversity of PittsburghCredit: CC0 Public DomainIt was a last-ditch effort. For years doctors had tried to keep a patient's recurrent drug-resistant ba
Breakthroughs March 14,2024
Netflix's 'You Are What You Eat' uses a twin study. Why studying twins is so important for science

Netflix's 'You Are What You Eat' uses a twin study. Why studying twins is so important for science

by Nathan Kettlewell,The ConversationStill from "You Are What You Eat." Credit: NetflixA new Netflix documentary, "You Are What You Eat," showcases sets of identical twins as
Breakthroughs March 14,2024
Netflix's 'You Are What You Eat' uses a twin study. Why studying twins is so important for science

Netflix's 'You Are What You Eat' uses a twin study. Why studying twins is so important for science

by Nathan Kettlewell,The ConversationStill from "You Are What You Eat." Credit: NetflixA new Netflix documentary, "You Are What You Eat," showcases sets of identical twins as
Breakthroughs March 14,2024
HIV: Early treatment is one key to remission

HIV: Early treatment is one key to remission

JANUARY 23, 2024 Editors' notesbyPasteur InstituteThe anti-SIV antibody levels after treatment interruption are associated with the magnitude of antigen stimulation. Kinetics of plasma anti-
Breakthroughs March 14,2024
HIV: Early treatment is one key to remission

HIV: Early treatment is one key to remission

JANUARY 23, 2024 Editors' notesbyPasteur InstituteThe anti-SIV antibody levels after treatment interruption are associated with the magnitude of antigen stimulation. Kinetics of plasma anti-
Breakthroughs March 14,2024
How does HIV get into the cell's center to kickstart infection?

How does HIV get into the cell's center to kickstart infection?

JANUARY 24, 2024 Editors' notesbyUniversity of New South WalesIntact HIV-1 CLPs penetrate Nup98 condensates via FG-binding pocket. Credit:Nature(2024). DOI: 10.1038/s41586-023-06
Breakthroughs March 14,2024
How does HIV get into the cell's center to kickstart infection?

How does HIV get into the cell's center to kickstart infection?

JANUARY 24, 2024 Editors' notesbyUniversity of New South WalesIntact HIV-1 CLPs penetrate Nup98 condensates via FG-binding pocket. Credit:Nature(2024). DOI: 10.1038/s41586-023-06
Breakthroughs March 14,2024
CRISPR and other new technologies open doors for drug development, but which diseases get prioritized?

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized?

DECEMBER 14, 2023 Editors' notesby C. Michael White,The ConversationCredit: Pixabay/CC0 Public DomainPrescription drugs and vaccines revolutionized health care, dramatically decreasing death
Breakthroughs March 14,2024
CRISPR and other new technologies open doors for drug development, but which diseases get prioritized?

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized?

DECEMBER 14, 2023 Editors' notesby C. Michael White,The ConversationCredit: Pixabay/CC0 Public DomainPrescription drugs and vaccines revolutionized health care, dramatically decreasing death
Breakthroughs March 14,2024
COPD and the effect of low-dose cadmium, a highly toxic metal, on airway epithelial cells

COPD and the effect of low-dose cadmium, a highly toxic metal, on airway epithelial cells

FEBRUARY 2, 2024 Editors' notesby Jeff Hansen,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainCigarette smoke exposure is associated with the development and severity of
Breakthroughs March 14,2024
COPD and the effect of low-dose cadmium, a highly toxic metal, on airway epithelial cells

COPD and the effect of low-dose cadmium, a highly toxic metal, on airway epithelial cells

FEBRUARY 2, 2024 Editors' notesby Jeff Hansen,University of Alabama at BirminghamCredit: Pixabay/CC0 Public DomainCigarette smoke exposure is associated with the development and severity of
Breakthroughs March 14,2024
Study: High Doses of Omega-3 Supplements May Not Be Heart-Healthy

Study: High Doses of Omega-3 Supplements May Not Be Heart-Healthy

ByStephanie BrownPublished on October 19, 2021Fact checked byAngela UnderwoodLonghua Liao/GettyKey TakeawaysA new meta-analysis found that people who took more than one gram of
Cardiovascular Diseases March 14,2024
Study: High Doses of Omega-3 Supplements May Not Be Heart-Healthy

Study: High Doses of Omega-3 Supplements May Not Be Heart-Healthy

ByStephanie BrownPublished on October 19, 2021Fact checked byAngela UnderwoodLonghua Liao/GettyKey TakeawaysA new meta-analysis found that people who took more than one gram of
Cardiovascular Diseases March 14,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com